First-Line Therapy for Patients With Multiple Myeloma: Direct and Indirect Comparison of Treatment Regimens on the Existing Market

Saved in:
Bibliographic Details
Published in:Value in health 2014-11, Vol.17 (7), p.A617-A617
Main Authors: Kuhr, K, Wirth, D, Srivastava, K, Lehmacher, W, Hellmich, M
Format: Article
Language:English
Subjects:
Internal Medicine
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c2509-ad259557210cff318735072b79c6088dad7c7ea5284c6aeefcb0d56db64bd533
cites
container_end_page A617
container_issue 7
container_start_page A617
container_title Value in health
container_volume 17
creator Kuhr, K
Wirth, D
Srivastava, K
Lehmacher, W
Hellmich, M
description
doi_str_mv 10.1016/j.jval.2014.08.2179
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1790458897</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S1098301514041096</els_id><sourcerecordid>1790458897</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2509-ad259557210cff318735072b79c6088dad7c7ea5284c6aeefcb0d56db64bd533</originalsourceid><addsrcrecordid>eNo9kU1v1DAQhiMEoh_wC5CQj1wSxnYcJxyQ0NJCpV2B6Eo9Wo4z6TrNF7ZTda_8chxt4TTvaN6Z0TyTJO8oZBRo8bHLukfdZwxonkGZMSqrF8k5FSxPc8n5y6ihKlMOVJwlF953AFBwJl4nZ0wyYLQQ58mfa-t8SLd2RLI_oNPzkbSTIz91sDgGT-5sOJDd0gc790h2R-ynQX8iX61DE4geG3IzNqdkMw2zdtZPI5lasneowxBnkF94b6PwJBbCAcnVk_XBjvdkp90DhjfJq1b3Ht8-x8tkf32133xPtz--3Wy-bFPDBFSpbpiohJCMgmlbTkvJBUhWy8oUUJaNbqSRqAUrc1NoxNbU0IiiqYu8bgTnl8mH09jZTb8X9EEN1hvsez3itHgV8UEuyrKS0cpPVuMm7x22anZ20O6oKKiVverUyl6t7BWUamUfu94_L1jqAZv_Pf9gR8PnkwHjlY8WnTK9Ha3R_QMe0XfT4sYIQFHlmQJ1u75v_R7NIY-64H8BIpCXGA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1790458897</pqid></control><display><type>article</type><title>First-Line Therapy for Patients With Multiple Myeloma: Direct and Indirect Comparison of Treatment Regimens on the Existing Market</title><source>BACON - Elsevier - GLOBAL_SCIENCEDIRECT-OPENACCESS</source><source>ScienceDirect Journals</source><creator>Kuhr, K ; Wirth, D ; Srivastava, K ; Lehmacher, W ; Hellmich, M</creator><creatorcontrib>Kuhr, K ; Wirth, D ; Srivastava, K ; Lehmacher, W ; Hellmich, M</creatorcontrib><identifier>ISSN: 1098-3015</identifier><identifier>EISSN: 1524-4733</identifier><identifier>DOI: 10.1016/j.jval.2014.08.2179</identifier><identifier>PMID: 27202165</identifier><language>eng</language><publisher>United States</publisher><subject>Internal Medicine</subject><ispartof>Value in health, 2014-11, Vol.17 (7), p.A617-A617</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2509-ad259557210cff318735072b79c6088dad7c7ea5284c6aeefcb0d56db64bd533</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,786,790,27957,27958</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27202165$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kuhr, K</creatorcontrib><creatorcontrib>Wirth, D</creatorcontrib><creatorcontrib>Srivastava, K</creatorcontrib><creatorcontrib>Lehmacher, W</creatorcontrib><creatorcontrib>Hellmich, M</creatorcontrib><title>First-Line Therapy for Patients With Multiple Myeloma: Direct and Indirect Comparison of Treatment Regimens on the Existing Market</title><title>Value in health</title><addtitle>Value Health</addtitle><subject>Internal Medicine</subject><issn>1098-3015</issn><issn>1524-4733</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNo9kU1v1DAQhiMEoh_wC5CQj1wSxnYcJxyQ0NJCpV2B6Eo9Wo4z6TrNF7ZTda_8chxt4TTvaN6Z0TyTJO8oZBRo8bHLukfdZwxonkGZMSqrF8k5FSxPc8n5y6ihKlMOVJwlF953AFBwJl4nZ0wyYLQQ58mfa-t8SLd2RLI_oNPzkbSTIz91sDgGT-5sOJDd0gc790h2R-ynQX8iX61DE4geG3IzNqdkMw2zdtZPI5lasneowxBnkF94b6PwJBbCAcnVk_XBjvdkp90DhjfJq1b3Ht8-x8tkf32133xPtz--3Wy-bFPDBFSpbpiohJCMgmlbTkvJBUhWy8oUUJaNbqSRqAUrc1NoxNbU0IiiqYu8bgTnl8mH09jZTb8X9EEN1hvsez3itHgV8UEuyrKS0cpPVuMm7x22anZ20O6oKKiVverUyl6t7BWUamUfu94_L1jqAZv_Pf9gR8PnkwHjlY8WnTK9Ha3R_QMe0XfT4sYIQFHlmQJ1u75v_R7NIY-64H8BIpCXGA</recordid><startdate>201411</startdate><enddate>201411</enddate><creator>Kuhr, K</creator><creator>Wirth, D</creator><creator>Srivastava, K</creator><creator>Lehmacher, W</creator><creator>Hellmich, M</creator><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201411</creationdate><title>First-Line Therapy for Patients With Multiple Myeloma: Direct and Indirect Comparison of Treatment Regimens on the Existing Market</title><author>Kuhr, K ; Wirth, D ; Srivastava, K ; Lehmacher, W ; Hellmich, M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2509-ad259557210cff318735072b79c6088dad7c7ea5284c6aeefcb0d56db64bd533</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Internal Medicine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kuhr, K</creatorcontrib><creatorcontrib>Wirth, D</creatorcontrib><creatorcontrib>Srivastava, K</creatorcontrib><creatorcontrib>Lehmacher, W</creatorcontrib><creatorcontrib>Hellmich, M</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Value in health</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kuhr, K</au><au>Wirth, D</au><au>Srivastava, K</au><au>Lehmacher, W</au><au>Hellmich, M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>First-Line Therapy for Patients With Multiple Myeloma: Direct and Indirect Comparison of Treatment Regimens on the Existing Market</atitle><jtitle>Value in health</jtitle><addtitle>Value Health</addtitle><date>2014-11</date><risdate>2014</risdate><volume>17</volume><issue>7</issue><spage>A617</spage><epage>A617</epage><pages>A617-A617</pages><issn>1098-3015</issn><eissn>1524-4733</eissn><notes>ObjectType-Article-1</notes><notes>SourceType-Scholarly Journals-1</notes><notes>ObjectType-Feature-2</notes><notes>content type line 23</notes><cop>United States</cop><pmid>27202165</pmid><doi>10.1016/j.jval.2014.08.2179</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1098-3015
ispartof Value in health, 2014-11, Vol.17 (7), p.A617-A617
issn 1098-3015
1524-4733
language eng
recordid cdi_proquest_miscellaneous_1790458897
source BACON - Elsevier - GLOBAL_SCIENCEDIRECT-OPENACCESS; ScienceDirect Journals
subjects Internal Medicine
title First-Line Therapy for Patients With Multiple Myeloma: Direct and Indirect Comparison of Treatment Regimens on the Existing Market
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-09-21T19%3A49%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=First-Line%20Therapy%20for%20Patients%20With%20Multiple%20Myeloma:%20Direct%20and%20Indirect%20Comparison%20of%20Treatment%20Regimens%20on%20the%20Existing%20Market&rft.jtitle=Value%20in%20health&rft.au=Kuhr,%20K&rft.date=2014-11&rft.volume=17&rft.issue=7&rft.spage=A617&rft.epage=A617&rft.pages=A617-A617&rft.issn=1098-3015&rft.eissn=1524-4733&rft_id=info:doi/10.1016/j.jval.2014.08.2179&rft_dat=%3Cproquest_cross%3E1790458897%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c2509-ad259557210cff318735072b79c6088dad7c7ea5284c6aeefcb0d56db64bd533%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1790458897&rft_id=info:pmid/27202165&rfr_iscdi=true